Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Bruker (BRKR) Acquisitions (2016 - 2026)

Bruker filings provide 14 years of Acquisitions readings, the most recent being $4.2 million for Q4 2025.

On a quarterly basis, Acquisitions fell 81.66% to $4.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $73.9 million, a 95.38% decrease, with the full-year FY2025 number at $73.9 million, down 95.38% from a year prior.
Acquisitions hit $4.2 million in Q4 2025 for Bruker, up from $200000.0 in the prior quarter.
In the past five years, Acquisitions ranged from a high of $1.3 billion in Q2 2024 to a low of $100000.0 in Q3 2022.
Median Acquisitions over the past 5 years was $20.0 million (2021), compared with a mean of $113.0 million.
Biggest five-year swings in Acquisitions: surged 119500.0% in 2023 and later crashed 99.83% in 2024.
Bruker's Acquisitions stood at $20.0 million in 2021, then soared by 384.0% to $96.8 million in 2022, then crashed by 95.56% to $4.3 million in 2023, then skyrocketed by 432.56% to $22.9 million in 2024, then plummeted by 81.66% to $4.2 million in 2025.
The last three reported values for Acquisitions were $4.2 million (Q4 2025), $200000.0 (Q3 2025), and $68.4 million (Q2 2025) per Business Quant data.